Literature DB >> 21652625

Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function.

Hannah Murdoch1, Suryakiran Vadrevu, Anke Prinz, Allan J Dunlop, Enno Klussmann, Graeme B Bolger, James C Norman, Miles D Houslay.   

Abstract

LIS1, a WD40 repeat scaffold protein, interacts with components of the cytoplasmic dynein motor complex to regulate dynein-dependent cell motility. Here, we reveal that cAMP-specific phosphodiesterases (PDE4s) directly bind PAFAH1B1 (also known as LIS1). Dissociation of LIS1-dynein complexes is coupled with loss of dynein function, as determined in assays of both microtubule transport and directed cell migration in wounded monolayers. Such loss in dynein functioning can be achieved by upregulation of PDE4, which sequesters LIS1 away from dynein, thereby uncovering PDE4 as a regulator of dynein functioning. This process is facilitated by increased intracellular cAMP levels, which selectively augment the interaction of long PDE4 isoforms with LIS1 when they become phosphorylated within their regulatory UCR1 domain by protein kinase A (PKA). We propose that PDE4 and dynein have overlapping interaction sites for LIS1, which allows PDE4 to compete with dynein for LIS1 association in a process enhanced by the PKA phosphorylation of PDE4 long isoforms. This provides a further example to the growing notion that PDE4 itself may provide a signalling role independent of its catalytic activity, exemplified here by its modulation of dynein motor function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652625      PMCID: PMC3113672          DOI: 10.1242/jcs.082982

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  56 in total

Review 1.  Kinesin and dynein superfamily proteins in organelle transport and cell division.

Authors:  N Hirokawa; Y Noda; Y Okada
Journal:  Curr Opin Cell Biol       Date:  1998-02       Impact factor: 8.382

2.  Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.

Authors:  E Huston; S Lumb; A Russell; C Catterall; A H Ross; M R Steele; G B Bolger; M J Perry; R J Owens; M D Houslay
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Reduction of microtubule catastrophe events by LIS1, platelet-activating factor acetylhydrolase subunit.

Authors:  T Sapir; M Elbaum; O Reiner
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  LIS1 and NudE induce a persistent dynein force-producing state.

Authors:  Richard J McKenney; Michael Vershinin; Ambarish Kunwar; Richard B Vallee; Steven P Gross
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

5.  The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram.

Authors:  E Huston; L Pooley; P Julien; G Scotland; I McPhee; M Sullivan; G Bolger; M D Houslay
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

6.  Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality.

Authors:  S Hirotsune; M W Fleck; M J Gambello; G J Bix; A Chen; G D Clark; D H Ledbetter; C J McBain; A Wynshaw-Boris
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

7.  Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells.

Authors:  D Belotti; M Rieppi; M I Nicoletti; A M Casazza; T Fojo; G Taraboletti; R Giavazzi
Journal:  Clin Cancer Res       Date:  1996-10       Impact factor: 12.531

8.  cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.

Authors:  R Hoffmann; I R Wilkinson; J F McCallum; P Engels; M D Houslay
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

9.  Cytoplasmic dynein and dynactin are required for the transport of microtubules into the axon.

Authors:  F J Ahmad; C J Echeverri; R B Vallee; P W Baas
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

10.  Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase.

Authors:  Cataldo Tarricone; Franco Perrina; Silvia Monzani; Lucia Massimiliano; Myung-Hee Kim; Zygmunt S Derewenda; Stefan Knapp; Li-Huei Tsai; Andrea Musacchio
Journal:  Neuron       Date:  2004-12-02       Impact factor: 17.173

View more
  8 in total

Review 1.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

2.  The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).

Authors:  Moses Xie; Brigitte Blackman; Colleen Scheitrum; Delphine Mika; Elise Blanchard; Tao Lei; Marco Conti; Wito Richter
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

3.  Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.

Authors:  Graeme B Bolger; Allan J Dunlop; Dong Meng; Jon P Day; Enno Klussmann; George S Baillie; David R Adams; Miles D Houslay
Journal:  Cell Signal       Date:  2014-12-27       Impact factor: 4.315

4.  Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.

Authors:  Kirsty F Houslay; Frank Christian; Ruth MacLeod; David R Adams; Miles D Houslay; George S Baillie
Journal:  Biochem J       Date:  2016-12-19       Impact factor: 3.857

5.  The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

Authors:  D J P Henderson; A Byrne; K Dulla; G Jenster; R Hoffmann; G S Baillie; M D Houslay
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

Review 6.  Mechanisms underlying the role of DISC1 in synaptic plasticity.

Authors:  Daniela Tropea; Neil Hardingham; Kirsty Millar; Kevin Fox
Journal:  J Physiol       Date:  2018-07       Impact factor: 5.182

7.  Fighting Cancer Stem Cell Fate by Targeting LIS1 a WD40 Repeat Protein.

Authors:  Felix M Brehar; Mihnea P Dragomir; George E D Petrescu; Radu M Gorgan
Journal:  Front Oncol       Date:  2019-10-31       Impact factor: 6.244

8.  DISC1 genetics, biology and psychiatric illness.

Authors:  Pippa A Thomson; Elise L V Malavasi; Ellen Grünewald; Dinesh C Soares; Malgorzata Borkowska; J Kirsty Millar
Journal:  Front Biol (Beijing)       Date:  2013-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.